InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.94
(
-0.01%
)
US TECH 100
17,723.60
(
0.23%
)
Dow Jones
39,459.56
(
-0.13%
)
Brent Oil
83.30
(
1.10%
)
Bitcoin
63,019.25
(
2.56%
)
Post# of 251806
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 829
Posts 119626
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Thursday, 09/24/2020 11:29:50 AM

Thursday, September 24, 2020 11:29:50 AM

Post# of 251806
TSHA IPOs 9.05M* shares @$20.00:

https://finance.yahoo.com/news/taysha-gene-therapies-announces-pricing-110000874.html

Taysha Gene Therapies [is] a patient-centric gene therapy company focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the central nervous system in both rare and large patient populations…

*Assuming exercise of underwriter’s option.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up